SCHEMBL529443

SCHEMBL529443

CCC(CC(N)=O)[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.31
HPGD P15428 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4735961 0.80 ALDH1A1 (0.33) ALDH1A1
SCHEMBL23829695 0.80 ALDH1A1 (0.39) ALDH1A1TSHRHPGDHIF1A
SCHEMBL1170869 0.80 ALDH1A1 (0.39) ALDH1A1TSHRHPGDHIF1A
SCHEMBL1170405 0.75
SCHEMBL17674174 0.75 TSHR (0.36) ALDH1A1TSHR
SCHEMBL4903792 0.74 TET2 (0.41) ALDH1A1
SCHEMBL17674207 0.74 GAA (0.41) ALDH1A1TSHRHPGD
SCHEMBL14836179 0.73
SCHEMBL635418 0.72
SCHEMBL29898494 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4396354-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF Wave Life Sciences Ltd. (SG) 2024-07-10 EP disclosed
WO-2023075766-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF WAVE LIFE SCIENCES LTD. (SG) 2023-05-04 WO disclosed
WO-2023049475-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2023-03-30 WO disclosed
EP-4153604-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF Wave Life Sciences Ltd. (SG) 2023-03-29 EP disclosed
EP-4125893-A1 TECHNOLOGIES FOR PREVENTING OR TREATING INFECTIONS Biohaven Therapeutics Ltd. (US) 2023-02-08 EP disclosed
EP-4061425-A1 DIRECTED CONJUGATION TECHNOLOGIES Kleo Pharmaceuticals, Inc. (US) 2022-09-28 EP disclosed
EP-4022059-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF Wave Life Sciences Ltd. (SG) 2022-07-06 EP disclosed
EP-3993818-A2 CD38-BINDING AGENTS AND USES THEREOF Kleo Pharmaceuticals, Inc. (US) 2022-05-11 EP disclosed
WO-2021237223-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2021-11-25 WO disclosed
WO-2021195401-A1 TECHNOLOGIES FOR PREVENTING OR TREATING INFECTIONS BIOHAVEN THERAPEUTICS LTD. (US) 2021-09-30 WO disclosed
WO-2021102052-A1 DIRECTED CONJUGATION TECHNOLOGIES KLEO PHARMACEUTICALS, INC. (US) 2021-05-27 WO disclosed
WO-2021071858-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF WAVE LIFE SCIENCES LTD. (SG) 2021-04-15 WO disclosed
WO-2021003050-A2 CD38-BINDING AGENTS AND USES THEREOF KLEO PHARMACEUTICALS, INC. (US) 2021-01-07 WO disclosed
EP-3630199-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF Wave Life Sciences Ltd. (SG) 2020-04-08 EP disclosed
WO-2018223056-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF WAVE LIFE SCIENCES LTD. (SG) 2018-12-06 WO disclosed
EP-2598170-A2 DRUG-LIGAND CONJUGATES, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO Smartcells, Inc. (US) 2013-06-05 EP disclosed
WO-2012015681-A2 DRUG-LIGAND CONJUGATES, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO SMARTCELLS, INC. (US) 2012-02-02 WO disclosed
CN-1051358-A Condensed imdazole derivatives and preparation method thereof FUJISAWA PHARMACEUTICAL CO (JP) 1991-05-15 CN disclosed